Nasdaq GlobeNewswire

LifeSci Advisors Expands Presence Into Europe

Del

NEW YORK, 2015-11-17 14:00 CET (GLOBE NEWSWIRE) -- LifeSci Advisors, LLC, (the "Company" or "LifeSci") an investor relations and corporate communications firm focused on the life sciences sector, today announced the appointment of Chris Maggos as Managing Director, Europe and the expansion of the Company's services to European clientele.

Mr. Maggos has over 20 years of experience in the life sciences industry covering business development, investor relations, public relations, journalism, and molecular biology. He is the founder of BioConfidant Sàrl, a Geneva-based strategic consulting firm that helped senior executives achieve their financing and partnering goals. Previously, while at Addex Therapeutics (SWX:ADXN), he was a member of the executive management board and held the positions of Head of Investor Relations & Communication from 2007 to 2010 and Director of Business Development from 2010 to 2013. Prior to Addex Therapeutics, Mr. Maggos was a journalist for BioCentury, a leading biotechnology trade publication, from 2001 to 2007. He began his career in the life sciences as a molecular biologist studying drug dependence at The Rockefeller University from 1993 to 1997, where he co-authored 12 peer-reviewed publications. He is also the co-Founder of the Alpine Institute for Drug Discovery, a not-for-profit social enterprise whose mission is to help commercialize academic discoveries. Mr. Maggos holds a BA in English Literature from Yale University, where he also completed pre-medical studies.

"Chris has an exceptional ability to help life sciences companies translate their value proposition to both the investment and scientific communities," said Andrew McDonald, Chief Executive Officer at LifeSci Advisors. "We have seen an increasing number of European companies seek introductions to the U.S. capital markets. With this hire, we look forward to expanding our presence in the region and serving as a valuable partner to those companies as they continue to develop their products and seek new sources of funding."

About LifeSci Advisors, LLC

LifeSci Advisors is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With local presence in New York, Boston, Chicago, and Geneva, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of Ph.D.s enables us to better understand our clients' R&D, regulatory, and commercial strategy, and our team of financial services, investor relations, and public relations specialists help our clients effectively communicate their strategies to the marketplace. This combination of life sciences, financial services, and investor relations expertise allows us to provide a valuable and unique service offering to our clients.

Visit our website:

www.lifesciadvisors.com

         CONTACT: For further information, please contact:
         
         Andrew I. McDonald Ph.D.
         Chief Executive Officer
         Tel.: (646) 597-6987
         
         Michael Rice
         President
         Tel.: (646) 597-6979

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

SoftServe Appoints Alex Chubay as Chief Technology Officer22.2.2018 13:00Pressemelding

Chubay to Champion the Next Phase of Innovation and Growth at World-Class Digital Consultancy AUSTIN, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading global digital authority and consulting company, today announces its appointment of Alex Chubay as Chief Technology Officer, effective immediately. Chubay will lead global IT functions and play a key role in shaping the company's technology capabilities and roadmap. He will be responsible for SoftServe's Centers of Excellence, comprising Experience Design, Solutions, Intelligent Enterprise, Critical Services, Digital Platforms; as well as research and development within the company. He will report to SoftServe's CEO, Chris Baker. "SoftServe has operated at the cutting edge of technology for a quarter century, and to continue that momentum - and most importantly to ensure our customers, partners, and associates are served well in the future - we are delighted to announce Alex Chubay's appointment as CTO," said Baker. "This ne

Valeritas Announces V-Go® Distribution Agreement in Italy with Movi SpA22.2.2018 13:00Pressemelding

BRIDGEWATER, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device, a simple, affordable, all-in-one insulin delivery option that is worn like a patch and can eliminate the need for taking multiple daily shots, today announced it has signed an exclusive distribution agreement with Movi SpA ("Movi") for the commercialization of V-Go Wearable Insulin Delivery device in Italy. Under the terms of the agreement, Valeritas has granted Movi the rights to promote, market, and sell the Company's flagship product V-Go Wearable Insulin Delivery device to diabetes clinics and patients in Italy. "We are thrilled to have Movi as our partner, and our distribution agreement is a significant first step to expand market access for V-Go Wearable Insulin Delivery device outside of the United States," said John Timberlake, CEO and President of Valeritas. "Movi is a truste

Magna Announces Fourth Quarter and 2017 Results and Raises Quarterly Cash Dividend by 20%22.2.2018 11:00Pressemelding

Fourth Quarter 2017 Highlights Record sales of $10.4 billion, up 12% from the fourth quarter of 2016 Record diluted earnings per share of $1.53, an increase of 23% Cash from operations of $1.4 billion Returned $461 million to shareholders through share repurchases and dividends Raises quarterly cash dividend by 20% to $0.33 per share Full Year 2017 Highlights Record sales of $38.9 billion, up 7% from 2016 Record diluted earnings per share of $5.90, an increase of 14% Record cash from operations of $3.3 billion Returned approximately $1.3 billion to shareholders through share repurchases and $400 million in dividends. AURORA, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA), a technology company and one of the world's largest automotive suppliers, today reported financial results for the fourth quarter and year ended December 31, 2017. THREE MONTHS ENDED DECEMBER 31, YEAR ENDED DECEMBER 31, 2017 2016 2017 2016 Reported Sales $ 10,391 $ 9,253 $ 38,9

Fortuna Updates Reserves and Resources22.2.2018 11:00Pressemelding

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines, Inc. (NYSE:FSM) (TSX:FVI) is pleased to report updated Mineral Reserve and Mineral Resource estimates as of December 31, 2017 for the Caylloma Mine located in Peru, the San Jose Mine located in Mexico and the Lindero Project in Argentina. Jorge A. Ganoza, President and CEO, commented: "Our infill drill programs at San Jose and Caylloma mines were successful at replenishing reserves mined in 2017." Mr. Ganoza continued, "In addition, the exploration programs over the last year at Caylloma have yielded a 92 percent increase in tonnes of Inferred Resources. This success underpins the potential for this mine to continue presenting opportunities to extend its life." Highlights of Reserve and Resource Update Combined Proven and Probable Reserves for the Caylloma and San Jose mines are reported at 6.6 Mt containing 44.8 Moz silver and 273 koz gold, representing year-over-year decreases of 2 percent and 7 perc

Percona Unveils Full Conference Session Schedule for the Annual Percona Live Open Source Database Conference 201822.2.2018 09:00Pressemelding

Sponsorship Opportunities Still Available, Advance Registration Discounts End March 4, 2018 RALEIGH, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MariaDB and MongoDB® and other open source database solutions and services, today announced the conference session schedule for the seventh annual Percona Live Open Source Database Conference 2018, taking place April 23-25, 2018 at the Santa Clara Convention Center in Santa Clara, Calif. Sponsorship opportunities for the conference are still available. Advance Registration Discounts can be purchased through March 4, 2018, 11:30 p.m. PST. Percona Live Open Source Database Conference 2018 is the premier open source database event. With a theme of "Championing Open Source Databases," the conference will feature multiple tracks, including MySQL, MongoDB, Cloud, PostgreSQL, Containers and Automation, Monitoring and Ops, and Database Security. Once again, Percona will be offering a low-cost dat

Aurora Advanced Flow Cytometry System from Cytek Biosciences Continues to Gain Traction22.2.2018 09:00Pressemelding

Patented, Unique, Differentiated Solution Embraced by Researchers around the Globe FREMONT, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- First introduced in June of last year, the Aurora advanced flow cytometry system from Cytek Biosciences Inc. has gained significant traction in the scientific community - and is setting the new standard for what is possible. Aurora has now been sold into four continents - Asia, North America, Australia, and Europe. Cytek's mission is to fill a gap in the industry by making high-dimensional flow cytometry accessible to a larger number of researchers - and the company has its sights set on the remaining three continents. Its superb performance has enabled the possibility of new discoveries and deeper biological insights at an affordable cost. Unlike other spectral flow cytometers, Aurora is a full spectrum flow cytometer based on Cytek's innovative architecture that does not use any optical dispersive element in its fluorescence detection system. The use o

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom